References
De Las PR, Ponce S, Henao F, Camps Herrero C, Carcereny E, Escobar Alvarez Y, Rodriguez CA, Virizuela JA, Lopez lopez R (2016) SIADH-related hyponatremia in hospital day care units: clinical experience and management with tolvaptan. Support Care Cancer: Off J Multinatl Assoc Support Care Cancer 24:499–507
Darmon M, Diconne E, Souweine B, Ruckly S, Adrie C, Azoulay E, Clec’h C, Garrouste-Orgeas M, Schwebel C, Goldgran-Toledano D, Khallel H, Dumenil AS, Jamali S, Cheval C, Allaouchiche B, Zeni F, Timsit JF (2013) Prognostic consequences of borderline dysnatremia: pay attention to minimal serum sodium change. Crit Care 17:R12
Spasovski G, Vanholder R, Allolio B, Annane D, Ball S, Bichet D, Decaux G, Fenske W, Hoorn EJ, Ichai C, Joannidis M, Soupart A, Zietse R, Haller M, van der Veer S, Van Biesen W, Nagler E (2014) Clinical practice guideline on diagnosis and treatment of hyponatraemia. Intensive Care Med 40:320–331
Beck LH (1979) Hypouricemia in the syndrome of inappropriate secretion of antidiuretic hormone. N Engl J Med 301:528–530
Dorhout Mees EJ, Blom van Assendelft P, Nieuwenhuis MG (1971) Elevation of uric acid clearance caused by inappropriate antidiuretic hormone secretion. Acta Medica Scandinavica 189:69–72
Castillo JJ, Vincent M, Justice E (2012) Diagnosis and management of hyponatremia in cancer patients. Oncologist 17:756–765
Darmon M, Pichon M, Schwebel C, Ruckly S, Adrie C, Haouache H, Azoulay E, Bouadma L, Clec’h C, Garrouste-Orgeas M, Souweine B, Goldgran-Toledano D, Khallel H, Argaud L, Dumenil AS, Jamali S, Allaouchiche B, Zeni F, Timsit JF (2014) Influence of early dysnatremia correction on survival of critically ill patients. Shock 41:394–399
Rondon-Berrios H, Berl T (2015) Mild chronic hyponatremia in the ambulatory setting: significance and management. Clin J Am Soc Nephrol: CJASN 10:2268–2278
Berl T (2015) Vasopressin antagonists. N Engl J Med 372:2207–2216
Gankam Kengne F, Couturier BS, Soupart A, Decaux G (2015) Urea minimizes brain complications following rapid correction of chronic hyponatremia compared with vasopressin antagonist or hypertonic saline. Kidney Int 87:323–331
Author information
Authors and Affiliations
Consortia
Corresponding author
Additional information
GrrrOH: Groupe de recherche en réanimation respiratoire en Onco-Hématologie (Group for Research in Respiratory Intensive Care Onco-Hematology; http://www.grrroh.com/)
Rights and permissions
About this article
Cite this article
Vincent, F., Ayed, S., Bouguerba, A. et al. Hyponatremia in solid-tumor cancer patients: uncertainty regarding the use of vaptans. Support Care Cancer 24, 3685–3686 (2016). https://doi.org/10.1007/s00520-016-3178-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-016-3178-2